| Aug 14, 2014
| 2:50 PM
The Securities and Exchange Commission is looking into the way that a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine, Calif.
Ackman's hedge fund, Pershing Square Capital Management,...
| Jul 25, 2014
| 7:43 AM
AbbVie Inc. said second-quarter earnings rose 2.8 percent, driven by double-digit sales growth of its arthritis drug Humira.
Earlier this month, the North Chicago-based company announced plans to acquire Irish drugmaker Shire PLC in a $54 billion dollar...
| Jul 19, 2014
AbbVie Inc. signed a nearly $55 billion deal to acquire drugmaker Shire PLC early Friday, a move that will allow it to substantially cut its corporate tax bill by moving its legal address to the United Kingdom.
The deal, announced by both companies in a...
| Jul 14, 2014
| 5:34 PM
In a decade, Americans have saved an estimated $1.2 trillion by taking generic drugs instead of the high-priced originals. But the booming market in copycat prescription pharmaceuticals - coupled with insurance companies' efforts to keep healthcare...
| Jul 14, 2014
| 10:37 AM
The pharmaceutical industry has been bragging for nearly a decade now about its efforts to help cash-strapped patients pay for expensive prescription drugs.
"An important safety net," the industry says, that has "already helped millions of Americans...
| Aug 8, 2014
| 1:46 PM
After several months as a customer of NuScriptRX, a 4-year-old pharmacy management company based in Nashville, Tenn., Sentara Healthcare has purchased a 12 percent share in the company.
The company has developed a fully automated on-site medication...
| Aug 7, 2014
| 5:31 PM
Bent and Henni Christensen consider themselves patriotic Americans and strong supporters of Medicare.
Nevertheless, the Huntington Beach couple buy most of their prescription drugs from an online Canadian pharmacy at prices much lower than in the United...
| Aug 7, 2014
| 12:11 PM
BOSTON (Reuters) - Concerned that trends in the economy may not help stock prices much, Janus Capital Group's Dan Kozlowski is looking for companies that can help themselves.
As manager of the $4.2 billion Janus Contrarian Fund, Kozlowski has posted...
| Aug 5, 2014
| 9:30 PM
Two American aid workers were gravely ill, fighting to survive infection with the deadly Ebola virus. A San Diego drug company had three doses of an experimental Ebola medicine that showed promise in monkeys but had never been tested in humans....
| Aug 4, 2014
| 9:11 PM
There is no vaccine or proven treatment for patients stricken with Ebola, but two ailing Americans who were infected with the deadly virus while working in the West African nation of Liberia have become test subjects for an experimental serum that they...
| Aug 2, 2014
| 5:00 AM
It's both endearing and infuriating to watch American corporate executives wring their hands about how the injustices of the U.S. tax code are forcing them — forcing them! — to reincorporate overseas through the procedure known as inversion....